<--- Back to Details
First PageDocument Content
Stem cells / Acute leukemia / Myeloid leukemia / Blood cells / T cells / Acute myeloid leukemia / CD34 / Interleukin / Hematopoietic stem cell / Biology / Cell biology / Oncology
Stem cells
Acute leukemia
Myeloid leukemia
Blood cells
T cells
Acute myeloid leukemia
CD34
Interleukin
Hematopoietic stem cell
Biology
Cell biology
Oncology

An upper limit for macromolecular crowding effects

Add to Reading List

Source URL: www.biomarkerres.org

Download Document from Source Website

File Size: 250,40 KB

Share Document on Facebook

Similar Documents

The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2

DocID: 1uSbg - View Document

A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan

DocID: 1uJQ2 - View Document

Vascular E-Selectin Mediates Chemo-Resistance in Acute Myeloid Leukemia Initiating Cells Via Canonical Receptors PSGL-1 (CD162) and Hcell (CD44) and AKT Signaling Ingrid G Winkler, PhD1*, Johanna M Erbani, PhD student2*,

DocID: 1u5Xi - View Document

Regulatory Perspective: Acute Leukemia Clinical Endpoints Nancy S. Scher, MD, FACP DODP, CDER, FDA 1

DocID: 1tdCV - View Document

· ACUTE LYMPHOBL ASTIC LEUKEMIA · Incorporating Antibodies into Treatment Strategies for Acute Lymphoblastic Leukemia Nicholas J. Short, MD, and Elias Jabbour, MD

DocID: 1shAS - View Document